These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 23746667)

  • 1. EGFR-directed treatments in SCCHN.
    Vokes EE; Seiwert TY
    Lancet Oncol; 2013 Jul; 14(8):672-3. PubMed ID: 23746667
    [No Abstract]   [Full Text] [Related]  

  • 2. Failure of anti-EGFR therapy in p16-positive head and neck cancer.
    Roesler R; Schwartsmann G
    Lancet Oncol; 2013 Oct; 14(11):e436-e437. PubMed ID: 24079865
    [No Abstract]   [Full Text] [Related]  

  • 3. Failure of anti-EGFR therapy in p16-positive head and neck cancer - authors' reply.
    Vermorken JB; Bach BA
    Lancet Oncol; 2013 Oct; 14(11):e437-e438. PubMed ID: 24079867
    [No Abstract]   [Full Text] [Related]  

  • 4. Combination therapy with bevacizumab and temsirolimus in squamous cell carcinoma of the head and neck.
    Bhatt VR; Ganti AK
    Oral Oncol; 2013 Aug; 49(8):e25. PubMed ID: 23631847
    [No Abstract]   [Full Text] [Related]  

  • 5. EGFR inhibition for recurrent or metastatic HNSCC.
    Argiris A
    Lancet Oncol; 2015 May; 16(5):488-9. PubMed ID: 25892143
    [No Abstract]   [Full Text] [Related]  

  • 6. The expanding role of systemic therapy in head and neck cancer.
    Cohen EE; Lingen MW; Vokes EE
    J Clin Oncol; 2004 May; 22(9):1743-52. PubMed ID: 15117998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing approaches to head and neck cancer. Metastatic head and neck cancer: new options.
    Licitra L; Locati LD; Bossi P
    Ann Oncol; 2008 Sep; 19 Suppl 7():vii200-3. PubMed ID: 18790949
    [No Abstract]   [Full Text] [Related]  

  • 8. [A combination of radiotherapy and chemotherapy with platidiam and fluorouracil in patients with head and neck cancer].
    Shparyk IaV; Kravets AI; Bilyns'kyĭ BT; Kuftiak OF
    Lik Sprava; 1996; (3-4):153-7. PubMed ID: 9035857
    [No Abstract]   [Full Text] [Related]  

  • 9. Head and neck cancer: second-line afatinib shows promise.
    Killock D
    Nat Rev Clin Oncol; 2015 Jul; 12(7):373. PubMed ID: 25940985
    [No Abstract]   [Full Text] [Related]  

  • 10. The SPECTRUM of findings in treatment options for recurrent/metastatic head and neck cancer.
    Misiukiewicz K; Posner M
    J Comp Eff Res; 2013 Nov; 2(6):533-5. PubMed ID: 24236791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperthermia as an adjuvant to radiation- and/or chemotherapy in far advanced recurrences of the head and neck region.
    Steindorfer P; Jakse R; Germann R; Schneider G; Berger A; Mischinger HJ; Rehak P
    Strahlenther Onkol; 1987 Jul; 163(7):449-52. PubMed ID: 2441480
    [No Abstract]   [Full Text] [Related]  

  • 12. [Combination of 5-fluorouracil and high doses of folinic acid in the treatment of recurrent and persistent spinocellular carcinoma of the head and neck. A phase II study].
    Bacigalupo A; Benasso M; Cavallari M; Merlano M; Sampietro M; Scasso F; Pallestrini E; Barbieri A; Cantoni E; Grimaldi A
    Acta Otorhinolaryngol Ital; 1988; 8(6):575-80. PubMed ID: 3266818
    [No Abstract]   [Full Text] [Related]  

  • 13. Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial.
    Vermorken JB; Stöhlmacher-Williams J; Davidenko I; Licitra L; Winquist E; Villanueva C; Foa P; Rottey S; Skladowski K; Tahara M; Pai VR; Faivre S; Blajman CR; Forastiere AA; Stein BN; Oliner KS; Pan Z; Bach BA;
    Lancet Oncol; 2013 Jul; 14(8):697-710. PubMed ID: 23746666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic chemotherapy with cisplatin plus 5-FU (PF) for recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): efficacy and safety of a lower dose of PF (80/800) at a single institution in Japan.
    Kiyota N; Tahara M; Kadowaki S; Fuse N; Doi T; Minami H; Ohtsu A
    Jpn J Clin Oncol; 2009 Apr; 39(4):225-30. PubMed ID: 19211574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II trial of docetaxel, cisplatin and 5-fluorouracil in patients with recurrent squamous cell carcinoma of the head and neck (SCCHN).
    Baghi M; Hambek M; Wagenblast J; May A; Gstoettner W; Knecht R
    Anticancer Res; 2006; 26(1B):585-90. PubMed ID: 16739325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paclitaxel, cisplatin, and 5-fluorouracil for patients with advanced or recurrent squamous cell carcinoma of the head and neck.
    Hussain M; Gadgeel S; Kucuk O; Du W; Salwen W; Ensley J
    Cancer; 1999 Dec; 86(11):2364-9. PubMed ID: 10590379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemo re-irradiation in recurrent head and neck cancer: a single institution experience.
    Katodritis N; Charalampous H; Vomvas D
    J BUON; 2012; 17(2):397. PubMed ID: 22740226
    [No Abstract]   [Full Text] [Related]  

  • 18. [Chemotherapy for patients with local-regional recurrent or metastatic carcinoma of the head and neck].
    Dufresne A; Gainet M; Stein U; Guardiola E; Pivot X
    Bull Cancer; 2003 Jan; 90(1):39-45. PubMed ID: 12609803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II evaluation of a 3-hour infusion of paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group study 0007.
    Worden FP; Moon J; Samlowski W; Clark JI; Dakhil SR; Williamson S; Urba SG; Ensley J; Hussain MH;
    Cancer; 2006 Jul; 107(2):319-27. PubMed ID: 16779801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paclitaxel (Taxol)/ifosfamide-based chemotherapy in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
    Shin DM
    Semin Oncol; 2000 Feb; 27(1 Suppl 1):36-40. PubMed ID: 10697043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.